325486-37-1

Basic information

• Product Name: N-Benzyl-3-(tert-butyldimethylsilanyloxymethyl)piperid-4-one
• Synonyms: N-Benzyl-3-(tert-butyldimethylsilanyloxymethyl)piperid-4-one;1-Benzyl-3-[(tert-butyldimethylsilyloxy)methyl]piperidin-4-one;N-Benzyl 3-(tert-butyl-dimethyl-silanyloxymethyl)-piperidin-4-one;1-Benzyl-3-[(tert-butyldimethylsilyloxy)methyl]piperidin-4-one 95%;N-BENZY 3-(TERT-BUTYLDIMETHYLSILANYLOXYMETHYL)PIPERID-4-ONE;1-Benzyl-3-{[(tert-butyldimethylsilyl)oxy]methyl}-4-oxopiperidine,[(1-Benzyl-4-oxopiperidin-3-yl)methoxy]tert-butyldimethylsilane;1-Benzyl-3-({[(tert-butyl)dimethylsilyl]oxy}methyl)piperidin-4-one95%;3-[[[(1,1-DIMETHYLETHYL)DIMETHYLSILYL]OXY]METHYL]-1-(PHENYLMETHYL)-4-PIPERIDINONE
• CAS NO: 325486-37-1
• Molecular Formula: C₁₉H₃₁NO₂Si
• Molecular Weight: 333.54044
• Mol File: 325486-37-1.mol
• Article Data: 2

Chemical Properties

• Boiling Point: 397.685 °C at 760 mmHg
• Flash Point: 194.313 °C
• Appearance: /
• Density: 0.997 g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.503
• PKA: 6.63±0.40(Predicted)
• CAS DataBase Reference: N-Benzyl-3-(tert-butyldimethylsilanyloxymethyl)piperid-4-one(CAS DataBase Reference)
• NIST Chemistry Reference: N-Benzyl-3-(tert-butyldimethylsilanyloxymethyl)piperid-4-one(325486-37-1)
• EPA Substance Registry System: N-Benzyl-3-(tert-butyldimethylsilanyloxymethyl)piperid-4-one(325486-37-1)

Safety Data

• Hazard Codes: C
• Hazardous Substances Data: 325486-37-1(Hazardous Substances Data)

Usage

General Description

N-Benzyl-3-(tert-butyldimethylsilanyloxymethyl)piperid-4-one is a chemical compound with the molecular formula C24H38NO2Si. It is a piperidone derivative that contains a benzyl group and a tert-butyldimethylsilanyloxymethyl group. N-Benzyl-3-(tert-butyldimethylsilanyloxymethyl)piperid-4-one has potential pharmacological and biological activities, and it may be used in medicinal chemistry research. Its structure and properties make it a promising candidate for the development of new drugs or as a building block in organic synthesis. Further studies and research are needed to fully understand its potential applications and effects.

InChI:InChI=1/C19H31NO2Si/c1-19(2,3)23(4,5)22-15-17-14-20(12-11-18(17)21)13-16-9-7-6-8-10-16/h6-10,17H,11-15H2,1-5H3

Upstream product

• 18162-48-6 tert-butyldimethylsilyl chloride 
• 97692-42-7 1-Benzyl-4-piperidon-3-carbonsaeuremethylester 
• 64996-15-2 (8-benzyl-1,4-dioxa-8-aza-spiro[4.5]dec-6-yl)-methanol 
• 3939-01-3 methyl 1-benzyl-4-oxopiperidine-3-carboxylate hydrochloride 
• 64996-14-1 8-benzyl-1,4-dioxa-8-aza-spiro[4.5]decane-6-carboxylic acid methyl ester 
• 214615-87-9 1-benzyl-3-hydroxymethyl-4-oxopiperidine 

Relevant articles and documents

CYCLOALKANOPYRIDINE DERIVATIVE

Provided are cycloalkanopyridine derivatives of formula [I]: [wherein the symbols are the same as those stated in the description]. The compounds act as a nociceptin receptor antagonist, and are useful as medicines for diseases associated with a nociceptin receptor, for example, as a reliever against tolerance to a narcotic analgesic; a reliever against dependence on or addiction to a narcotic analgesic; an analgesic enhancer; an antiobesitic or appetite suppressor; a treating or prophylactic agent for cognitive impairment and dementia/amnesia; an agent for treating developmental cognitive abnormality; a remedy for schizophrenia; an agent for treating neurodegenerative diseases; an anti-depressant or treating agent for affective disorder; a treating or prophylactic agent for diabetes insipidus; a treating or prophylactic agent for polyuria; or a remedy for hypotension.